Evolution Wealth Advisors, LLC Amicus Therapeutics, Inc. Transaction History

Evolution Wealth Advisors, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$9.82 - $12.44 $4,733 - $5,996	-482 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$8.74 - $11.84 $3,277 - $4,440	-375 Reduced 43.76%	482 $5,000
Q2 2021 Jul 22, 2021	BUY	$8.71 - $10.72 $600 - $739	69 Added 8.76%	857 $8,000
Q1 2021 Apr 20, 2021	SELL	$9.2 - $23.86 $1,306 - $3,388	-142 Reduced 15.27%	788 $8,000
Q4 2020 Feb 02, 2021	SELL	$13.47 - $24.89 $11,058 - $20,434	-821 Reduced 46.89%	930 $21,000
Q1 2020 Apr 22, 2020	BUY	$6.63 - $11.16 $3,686 - $6,204	556 Added 46.53%	1,751 $16,000
Q4 2019 Feb 03, 2020	BUY	$7.48 - $10.75 $8,115 - $11,663	1,085 Added 986.36%	1,195 $12,000
Q3 2019 Nov 12, 2019	SELL	$8.02 - $13.25 $9,415 - $15,555	-1,174 Reduced 91.43%	110 $1,000
Q2 2019 Jul 12, 2019	BUY	$10.96 - $14.4 $14,072 - $18,489	1,284 New	1,284 $16,000

313

314M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.79B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.